trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['lung', 'destiny,lung02']
results from interim analysis of destiny-lung02 phase 2 trial presented at esmo see the rest of the story here. provides the latest financial news as it breaks. known as a leader in market intelligence, the fly's real-time, strea 